Private hospitals have slashed the prices of SII’s Covishield and Bharat Biotech’s Covaxin vaccines to 225 per dose in a major move. Adar Poonawala, CEO of...
Hydebarab’s Bharat Biotech announced on Wednesday that the Central Pharmaceutical Standards Control Organization has extended the shelf life of Covaxin to up to 12 months from...
The Centre today told the Kerala High Court that those who have been administered both doses of the anti-coronavirus vaccine cannot be re-vaccinated. A man from...
Every batch of Covaxin, the indigenous vaccine against Covid-19 developed by Hyderabad-based Bharat Biotech, undergoes over 200 quality-control tests and then the samples are submitted to...
All documents required for Emergency Use Listing (EUL) have been submitted to WHO by Bharat Biotech for COVID-19 vaccine Covaxin as of July 9 and the...
Bharat Biotech’s Covaxin is overall 77.8 per cent effective against Covid, the vaccine maker said today in a statement, citing the data from the third phase...
Covaxin, India’s first indigenous COVID-19 vaccine, is expected to be available for children by September, Delhi AIIMS chief Dr. Randeep Guleria told a news channel. In...
Hyderabad-based company Bharat Biotech has handed over the data of Phase-3 clinical trial of Covaxin to the government. News agency ANA quoted sources as saying that...
This is a consequence of the US FDA asking the company to launch an additional trial so that the company can file for a Biologics Licence...
Covaxin in Delhi will be administered only to those in the 18-44 age group who need the second dose, the Delhi government said in a statement...
